These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18438336)

  • 1. Antineoplastic and apoptotic effects of cannabinoids. N-acylethanolamines: protectors or killers?
    Pushkarev VM; Kovzun OI; Tronko MD
    Exp Oncol; 2008 Mar; 30(1):6-21. PubMed ID: 18438336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
    Oesch S; Gertsch J
    J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and function.
    Schmid HH; Berdyshev EV
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):363-76. PubMed ID: 12052050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumorigenic effects of cannabinoids beyond apoptosis.
    Freimuth N; Ramer R; Hinz B
    J Pharmacol Exp Ther; 2010 Feb; 332(2):336-44. PubMed ID: 19889794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
    Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
    Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoids in the immune system and cancer.
    Parolaro D; Massi P; Rubino T; Monti E
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):319-32. PubMed ID: 12052046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the endocannabinoid system in cancer therapy: a call for further research.
    Bifulco M; Di Marzo V
    Nat Med; 2002 Jun; 8(6):547-50. PubMed ID: 12042794
    [No Abstract]   [Full Text] [Related]  

  • 8. [The endocannabinoid system as a target for the development of new drugs for cancer therapy].
    Bifulco M; Di Marzo V
    Recenti Prog Med; 2003 May; 94(5):194-8. PubMed ID: 12723496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cannabinoid system and male reproductive functions.
    Rossato M; Pagano C; Vettor R
    J Neuroendocrinol; 2008 May; 20 Suppl 1():90-3. PubMed ID: 18426506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids as potential anti-epileptic drugs.
    Smith PF
    Curr Opin Investig Drugs; 2005 Jul; 6(7):680-5. PubMed ID: 16044663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothesis: cannabinoid therapy for the treatment of gliomas?
    Velasco G; Galve-Roperh I; Sánchez C; Blázquez C; Guzmán M
    Neuropharmacology; 2004 Sep; 47(3):315-23. PubMed ID: 15275820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid-associated cell death mechanisms in tumor models (review).
    Calvaruso G; Pellerito O; Notaro A; Giuliano M
    Int J Oncol; 2012 Aug; 41(2):407-13. PubMed ID: 22614735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids.
    Oz M
    Pharmacol Ther; 2006 Jul; 111(1):114-44. PubMed ID: 16584786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids in pain and inflammation.
    Mbvundula EC; Rainsford KD; Bunning RA
    Inflammopharmacology; 2004; 12(2):99-114. PubMed ID: 15265314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Endocannabinoid System: A Target for Cancer Treatment.
    Laezza C; Pagano C; Navarra G; Pastorino O; Proto MC; Fiore D; Piscopo C; Gazzerro P; Bifulco M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review).
    Bifulco M; Laezza C; Gazzerro P; Pentimalli F
    Oncol Rep; 2007 Apr; 17(4):813-6. PubMed ID: 17342320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid receptor systems: therapeutic targets for tumour intervention.
    Jones S; Howl J
    Expert Opin Ther Targets; 2003 Dec; 7(6):749-58. PubMed ID: 14640910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrospray ionization mass spectrometric method for the determination of cannabinoid precursors: N-acylethanolamine phospholipids (NAPEs).
    Hansen HH; Hansen SH; Bjørnsdottir I; Hansen HS
    J Mass Spectrom; 1999 Jul; 34(7):761-7. PubMed ID: 10407361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of cannabinoids.
    Grotenhermen F
    Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
    Ligresti A; Moriello AS; Starowicz K; Matias I; Pisanti S; De Petrocellis L; Laezza C; Portella G; Bifulco M; Di Marzo V
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1375-87. PubMed ID: 16728591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.